← Back to Clinical Trials
Recruiting NCT06771102

NCT06771102 Performance Characteristics and Technical Outcomes of Single-use Gastroscopes Used Bedside Versus Reusable Gastroscopes Used in the Endoscopy Unit Evaluated in Subacute Patients

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06771102
Status Recruiting
Phase
Sponsor Zealand University Hospital
Condition Upper Gastrointestinal Disorder
Study Type INTERVENTIONAL
Enrollment 180 participants
Start Date 2025-01-13
Primary Completion 2027-01

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type INTERVENTIONAL
Interventions
Ambu aScope GastroDiagnostic gastroscopes, Olympus

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 180 participants in total. It began in 2025-01-13 with a primary completion date of 2027-01.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The aim of this study is to investigate whether single-use gastroscopes used bedside can reduce the time from indication to procedure compared with re-usable gastroscopes used at the endoscopy unit in patients referred to a subacute gastroscopy. Participants in the first period will be scheduled for gastroscopy with a re-usable gastroscope in the endoscopy unit, whereas participants during the second period will have a gastroscopy performed at the ward (bed-side) with a single-use gastroscope.

Eligibility Criteria

Inclusion Criteria: * Patients of any gender, 18 years of age or older admitted to the acute section of the surgical department (Kir2) at Zealand University Hospital referred to early EGD without general anesthesia. Exclusion Criteria: * ASA-score of 4 or higher * Unstable patient * Suspicion of ventricular retention * Suspicion of active bleeders * Need for expert endoscopist to perform the procedure, e.g. stenting * Patients \< 18 years of age

Contact & Investigator

Central Contact

Camilla Kjelkvist-Born, MD

✉ camkj@regionsjaelland.dk

📞 +4528263875

Principal Investigator

Lasse Bremholm Hansen, PhD, ass.prof

STUDY CHAIR

Surgical department of Zealand University Hospital

Frequently Asked Questions

Who can join the NCT06771102 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Upper Gastrointestinal Disorder. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06771102 currently recruiting?

Yes, NCT06771102 is actively recruiting participants. Contact the research team at camkj@regionsjaelland.dk for enrollment information.

Where is the NCT06771102 trial being conducted?

This trial is being conducted at Køge, Denmark.

Who is sponsoring the NCT06771102 clinical trial?

NCT06771102 is sponsored by Zealand University Hospital. The principal investigator is Lasse Bremholm Hansen, PhD, ass.prof at Surgical department of Zealand University Hospital. The trial plans to enroll 180 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology